Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) shares rose 4.4% during mid-day trading on Friday . The company traded as high as $18.86 and last traded at $18.30. Approximately 6,240 shares were traded during trading, a decline of 77% from the average daily volume of 26,930 shares. The stock had previously closed at $17.53.
Analyst Ratings Changes
TLX has been the subject of a number of research analyst reports. William Blair reaffirmed an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday, March 12th. UBS Group raised their target price on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a report on Monday, January 27th.
Telix Pharmaceuticals Limited American Depositary Shares Stock Performance
About Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
Read More
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- How to Find Undervalued Stocks
- FedEx Delivers Another Crushing Blow to Its Stock Price
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- What is Short Interest? How to Use It
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
